Mobile application communication may improve palliative care needs met in critically ill patients
1. Families randomized to having access to a mobile application that allowed them to communicate needs with intensive care unit ...
1. Families randomized to having access to a mobile application that allowed them to communicate needs with intensive care unit ...
1. In this randomized controlled trial, rates of ventilator-associated pneumonia (VAP) were lower in ventilated patients using amikacin as compared ...
1. In this randomized controlled trial, ventilator-associated pneumonia (VAP) was prevented by employing inhaled amikacin in mechanically ventilated patients exceeding ...
1. In this randomized controlled trial, tight versus liberal blood glucose control resulted in similar intensive care unit (ICU) outcomes. ...
Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be ...
1. For critically ill patients hospitalized for COVID-19, P2Y12 inhibitors did not improve organ support-free days or survival to discharge ...
1. In this retrospective cohort study, patients with sepsis and high-mean arterial pressure (MAP) management had a significantly lower 30-, ...
1. In this trial emulation study, molnupiravir and nirmatrelvir-ritonavir reduced all-cause mortality in vaccinated and unvaccinated hospitalized patients with coronavirus ...
1. Time-to-discharge-alive from the hospital was similar among both high- and regular-protein groups. 2. There was no significant inter-group difference ...
1. In this scoping review, critical care staff who were spiritual experienced greater moral distress due to a lack of ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.